P
Protalix BioTherapeutics, Inc. (PLX)
ASE – Real vaqt narxi. Valyuta: USD
2.30
+0.08 (3.60%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.30
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:07 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
2.30
+0.08 (3.60%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.30
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:07 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $41.7M umumiy qarzdan $8.5M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $86.4M jami joriy majburiyatlardan $27.4M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.1) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (110x) kompaniya qarz to'lovlarini osonlik bilan boshqarishini ko'rsatadi
Kompaniya ijobiy erkin pul oqimi $21.3M generatsiya qiladi, moliyaviy salomatligini qo'llab-quvvatlaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.15 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 2.04 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.13 | 0.30 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.08 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | 109.56 | -16.91 | 10 | |
| O‘rtacha ball | 9.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 48M | 65M | 53M | 53M | 76M |
| Yalpi foyda | 28M | 43M | 29M | 25M | 53M |
| Operatsion daromad | -13M | 10M | 4M | -6M | 20M |
| Sof foyda | -15M | 8M | 3M | -7M | 15M |
| EBITDA | -12M | 12M | 5M | -4M | 21M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | -17.29 | N/A | 1.0 |
| Keyingi chorak | -16.7 | -133.33 | 1.0 |
| Joriy yil | 48.44 | 343.75 | 10 |
| Keyingi yil | -13.71 | -74.36 | 1.0 |
| O‘rtacha ball | 3.3 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 269.98 | 432.79 | 466.67 | 1206.95 | 10 |
| Yil/Yil | 233.73 | 606.13 | 540 | 496.42 | 10 |
| 3 yil o‘rtacha | 5.93 | -78.08 | -75.49 | 68.54 | 4.3 |
| 5 yil o‘rtacha | 0.6 | -102.23 | -71.65 | 28.71 | 3.5 |
| O‘rtacha ball | 7.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |